Cargando…
Advances in the Design of (Nano)Formulations for Delivery of Antisense Oligonucleotides and Small Interfering RNA: Focus on the Central Nervous System
[Image: see text] RNA-based therapeutics have emerged as one of the most powerful therapeutic options used for the modulation of gene/protein expression and gene editing with the potential to treat neurodegenerative diseases. However, the delivery of nucleic acids to the central nervous system (CNS)...
Autores principales: | Mendonça, Monique C. P., Kont, Ayse, Aburto, Maria Rodriguez, Cryan, John F., O’Driscoll, Caitriona M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824433/ https://www.ncbi.nlm.nih.gov/pubmed/33734715 http://dx.doi.org/10.1021/acs.molpharmaceut.0c01238 |
Ejemplares similares
-
Cyclodextrin-Based Nanoparticles for Delivery of Antisense Oligonucleotides Targeting Huntingtin
por: Mendonça, Monique C. P., et al.
Publicado: (2023) -
Co-Formulation of Amphiphilic Cationic and Anionic Cyclodextrins Forming Nanoparticles for siRNA Delivery in the Treatment of Acute Myeloid Leukaemia
por: Kont, Ayse, et al.
Publicado: (2022) -
Antisense Oligonucleotides and Small Interfering RNA for the Treatment of Dyslipidemias
por: Gareri, Clarice, et al.
Publicado: (2022) -
Cationic and PEGylated Amphiphilic Cyclodextrins: Co-Formulation Opportunities for Neuronal Sirna Delivery
por: O’Mahony, Aoife M., et al.
Publicado: (2013) -
The blood-brain barrier in aging and neurodegeneration
por: Knox, Emily G., et al.
Publicado: (2022)